Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer (Q38894951)

7 September 2017

Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer (English)

1 reference

7 September 2017

Jingyue Sun

1

1 reference

7 September 2017

Nan Du

2

1 reference

7 September 2017

Jin Li

3

1 reference

7 September 2017

Jianwei Zhou

4

1 reference

7 September 2017

Guoquan Tao

5

1 reference

7 September 2017

Suan Sun

6

1 reference

7 September 2017

Jingdong He

7

1 reference

7 September 2017

25 March 2015

1 reference

Technology in Cancer Research and Treatment

7 September 2017

1 reference

7 September 2017

15

1 reference

7 September 2017

2

1 reference

7 September 2017

285-295

1 reference

7 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Epidemiology, pathology and clinical management of multiple gastric cancers: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Advances in the treatment of patients with gastric adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

The AP-2 family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

TFAP2E-DKK4 and chemoresistance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

TFAP2E hypermethylation was associated with survival advantage in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Immunohistochemical analysis of thymidylate synthase, p16(INK4a), cyclin-dependent kinase 4 and cyclin D1 in colorectal cancers receiving preoperative chemotherapy: significance of p16(INK4a)-mediated cellular arrest as an indicator of chemosensitiv

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

The role of mutations in epigenetic regulators in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Identification of amino acid residues of transcription factor AP-2 involved in DNA binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Characterization of the activation domains of AP-2 family transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Analysis of the DNA-binding and activation properties of the human transcription factor AP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Identification of novel epigenetic markers for clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Wwox and Ap2gamma expression levels predict tamoxifen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Identification and embryonic expression of a new AP-2 transcription factor, AP-2 epsilon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533034615577028

21 January 2018

Identifiers

DOI

10.1177/1533034615577028

1 reference

7 September 2017

1 reference